Barclays PLC : Close to important levels
Published may 20, 2015 at 04:55 am edt
By
Entry price | Target | Stop-loss | Potential |
---|
GBX 263.55 |
GBX 0 |
GBX 270.8 |
+100% |
---|
Coming back to the resistance at GBp 266 may stimulate price's relapse toward the support.
Fundamentals about Barclays remain extremely volatile. The company is worth 16 times estimated earnings, this valuation level of the group isn't justified. The company's market capitalization discounted of liabilities represents almost 1.71 times its sales, which is part of worst odds. Analysts revised downwards the EPS estimates of the group and it announces important falls to come in terms of profitability and a slowdown in their activity.
Technically, Barclays failed again to breakout the GBp 266 resistance despite many tests since the beginning of the year. Moreover, this area correspond to the weekly resistance which has not been broke out for months. In this case we can anticipate a downward movement coming towards the GBp 242.6 which is the lower band of the recent trading range.
Most active investors could open short positions on Barclays close to GBp 266. The target being set at GBp 242.6, or a potential gain of 7%. A stop loss could be placed at GBp 270.8.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.